Skip to search formSkip to main contentSkip to account menu

Vaccines, Synthetic

Known as: Immunogens, Synthetic, Synthetic vaccines, Synthetic Immunogens 
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA… 
National Institutes of Health

Related topics

Related topics

22 relations

Narrower (13)

ALVAC-CEA vaccineEuvax-BGI 5005RTS,S-AS01 vaccine

Broader (2)

Antigens, SyntheticVaccines
BiotechnologyIn BloodMicrobiologicalVaccines, Peptide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Automated carbohydrate synthesis as platform to address fundamental aspects of glycobiology--current status and future challenges.
Highly Cited
2004
Highly Cited
2004
Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
Vaccines derived from totally synthetic carbohydrate antigens have been shown to elicit an immune response in both preclinical… 
Review
1999
Review
1999
Developing recombinant and synthetic vaccines for the treatment of melanoma.
To develop new vaccines for the treatment of patients with cancer, target antigens presented on tumor cell surfaces have been… 
Highly Cited
1996
Highly Cited
1996
Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.
Highly Cited
1995
Highly Cited
1995
Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes.
Highly Cited
1994
Highly Cited
1994
Crystal structure of the principal neutralization site of HIV-1.
The crystal structure of a complex between a 24-amino acid peptide from the third variable (V3) loop of human immunodeficiency… 
Highly Cited
1992
Highly Cited
1992
A chemically defined synthetic vaccine model for HIV-1.
Multiple Ag peptide (MAP) system without the use of a protein carrier was used as a vaccine model in three species of animals… 
Highly Cited
1992
Highly Cited
1992
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen.
Highly Cited
1990
Highly Cited
1990
Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.
During the development of a synthetic vaccine for human use against the asexual blood stages of Plasmodium falciparum, monkey… 
Review
1983
Review
1983
Synthetic peptide immunogens as vaccines.
Synthetic peptide immunogens have been shown to elicit antibodies that can react with full-length proteins containing that… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)